A look back at what we've been covering on "CBS This Morning." Subscribe to get the Eye Opener delivered straight to your inbox.
And we have 4 pricing tiers, 1 through 4, and we see our value spreads really more specifically, in 2, 3 and 4 that's even a little wider that we're going to continue to take a look at throughout the remainder of this year and as we move forward. But we feel our value spreads have been there for a while. Operator 
To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. In the last half decade Navigator Holdings saw its share price fall as its EPS declined below zero.
Taken together with incremental vessel operating contribution expected to be obtained with the entry of the Overseas Key West into our trading fleet in April, we anticipate that 2019 cash flow contribution from our conventional tanker fleet will improve by approximately $20 million over results achieved in 2018. We believe the continuing revenue potential that remains latent within our conventional tanker fleet beyond 2019 is notable. Considered that our most recent 12-month time charter contract was made at close to $60,000 per day and that all 10 of our conventional tankers will come open for negotiations to reset pricing over the next 12 months, an increase in average earnings of these ve...
What happened Shares of Roku (NASDAQ: ROKU) were down 13% on Wednesday afternoon after receiving a pair of downgrades from analysts who believe the stock has appreciated too much too quickly and are worried about its upside from here. So what Roku has been one of the market's top performers year to date, up more than 120% for the year prior to Wednesday's drop and still up 100% even after the sell-off. The company has enjoyed strong success in its transition from being purely a hardware maker toward adding content, ending 2018 with more than 27 million active accounts.
Aurora Cannabis stock soars over 10% after the company announced the appointment of U.S. billionaire Nelson Peltz as strategic adviser. Peltz is the founding partner of alternative investment firm Trian Fund Management, bringing his knowledge of the consumer goods industry. Yahoo Finance's Heidi Chung joins Akiko Fujita.
Cloudera Inc. (cldr) shares fell more than 10% in after-hours trading Wednesday after the company said that losses in the fourth quarter were wider than expected, and forecast more red ink this year as Hortonworks is integrated. Cloudera, which closed its acquisition of rival Hortonworks in early January, said fourth-quarter losses totaled $85.5 million, or 45 cents a share, on sales of $144.5 million, up from $105.7 million a year ago. After adjusting for stock-based compensation and other effects, Cloudera reported a loss of 15 cents a share, worse than last year's 10 cents a share loss.
To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Hikma Pharmaceuticals Plc on Wednesday forecast growth in 2019 for its injectable drugs division, as strong demand along with a rebound in its generics business helped it post a 19 percent jump in full-year core operating profit. However, the double-digit growth fell short of analysts' average expectations. The company has been strengthening its injectable drugs unit - its largest - through new medicines.
Shares of would-be gold miner Northern Dynasty Minerals (NYSEMKT: NAK) took an 11% tumble in early trading Wednesday before retracing to close the day down "only" 3.7%. The decline appears tied to an announcement Northern Dynasty made this morning to the effect that banks Cantor Fitzgerald Canada, BMO Capital Markets, H.C. Wainwright & Co., and TD Securities have agreed to purchase at least 15.6 million shares of its stock at $0.64 per share -- raising "gross proceeds" of $10 million for Northern Dynasty to use -- and potentially 2.3 million more shares, which would add another $1.5 million. Three weeks ago, Northern Dynasty stock enjoyed a brief moment in the sun when the U.S. Army Corps of Engineers issued its Draft Environmental Impact Statement on Northern Dynasty's southwest Alaskan Pebble Project to develop a gold mine.
Airline pilots on at least two U.S. flights have reported that an automated system seemed to cause their Boeing 737 Max planes to tilt down suddenly. The pilots said that soon after engaging the autopilot on Boeing 737 Max 8 planes, the nose tilted down sharply. In both cases, they recovered quickly after disconnecting the autopilot.
AT&T is raising prices for its DirecTV Now streaming TV service, while removing some networks from the cable-like television package. The changes come just weeks after a U.S. appeals court upheld the company's Time Warner takeover. The Justice Department fought it, arguing it would lead to higher prices.
The stock market has been moving sharply higher lately, and Wednesday was no exception. Express (NYSE: EXPR), Roku (NASDAQ: ROKU), and Insys Therapeutics (NASDAQ: INSY) were among the worst performers. Shares of Express dropped 10% following the apparel retailer's release of its fourth-quarter financial results.
Wednesday was another positive day on Wall Street, as market participants reacted favorably to signs that business investment remains strong. Oaktree Capital Group (NYSE: OAK), Guardant Health (NASDAQ: GH), and Clean Energy Fuels (NASDAQ: CLNE) were among the top performers. Investors in Oaktree Capital Group enjoyed a gain of more than 12% in the value of their investment after the asset management company announced that industry peer Brookfield Asset Management (NYSE: BAM) had agreed to purchase a 62% stake in Oaktree's overall business.
Estimates suggest that Lyft will garner a valuation between $20 billion and $25 billion when it files for its IPO, while Uber will likely be in excess of $100 billion and perhaps push up toward $120 billion. Do investors realize that would almost make Uber more valuable than Tesla , General Motors and Ford combined? These valuations, particularly Lyft's because it's smaller and going first, could skyrocket if we only get a sliver deal.
Shares of Akari Therapeutics PLC (aktx) more than doubled--soaring 145%--toward a 15-month high in very active morning trade Wednesday, enough to pace all the gainers on the Nasdaq exchange, after the company said it plans to commence trials in European and U.S. pediatric patients this year for its treatment of pediatric thrombotic microangiopathy. The company said it had a "successful," pre-investigational new drug (IND) meeting with the Food and Drug Administration regarding its pivotal clinical trial program for pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA), which is an orphan condition with an estimated fatality rate of 80%. Chief Executive Clive Richardson said trials in HSCT-TMA patients are planned to begin in the fourth quarter.
Carnival Cruises stock rising on Goldman Sachs price target upgrade to $65 citing rising capacity that can boost fundamentals. Yahoo Finance's Heidi Chung joins Akiko Fujita.
Take a look instead at Scope 3 emissions – those that result when the products are consumed – and a very different picture emerges: On that measure, of resources companies for which Bloomberg has data only Royal Dutch Shell Plc is a bigger emitter than Rio and BHP, both of which feature on S&P Global Inc. s Dow Jones Sustainability Indexes. Soot-stained coal dinosaurs like Glencore, and Exxaro Resources Ltd. come in well down the ranking.
Investors weren't thrilled the day of the announcement, sending Bristol lower, but for the most part it seemed like just the latest in a string of big pharma mergers. However, last month, activist investor Starboard Value announced it had taken a stake in Bristol-Myers and in a rare move, Wellington Management, Bristol-Myers' biggest institutional shareholder, came out publicly against the merger, a position that Starboard echoed. Many investors worried if the deal might fall apart, although analysts are still optimistic that it will.
EXEL's strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. This suggests prudent control over cash and cost by management, which is an important determinant of the company's health. EXEL seems to have put its debt to good use, generating operating cash levels of 27.78x total debt in the most recent year.
On Aug. 2, 2018, something happened that had never before occurred on an American stock exchange: Apple's (NASDAQ: AAPL) total value surpassed the $1 trillion valuation mark. Both stocks have sunk since then, and neither has a market capitalization of more than $1 trillion anymore. Of course, Apple and Amazon could shoot back up, but there are three other companies that seem quite capable of hitting $1 trillion -- maybe even in 2019.
Fourth-quarter revenue was $96.2 million, up 8% from last year, while GAAP net income came in at $6.9 million, compared to a $28.3 million net loss in the year-ago period. Because natural gas commodity prices can swing wildly, looking at revenue alone doesn't always show whether the company is actually growing. A measure that better shows what's happening with demand for its core business -- selling natural gas and renewable natural gas to transportation customers -- is volume, measured in gallon-equivalents, and this metric surged 14.2% higher in the quarter.
Roku Inc. (roku) shares dropped more than 10% in Wednesday trading, turning around after more than doubling to kick off 2019. In downgrading the stock to neutral from outperform Wednesday morning, Macquarie Research analyst Tim Nollen noted that shares were up 131% in 2019 to that point and wrote, "we believe it is difficult to justify the valuation." Nollen was one of two analysts to downgrade the stock Wednesday, while Suntrust Robinson Humphrey analyst Matthew Thornton increased his price target to $63 from $42 while maintaining a hold rating.
What happened Shares of the small-cap oncology specialist Verastem (NASDAQ: VSTM) fell by as much as 19.1% on nearly double the average daily volume in early morning trading today. Verastem's shares have since recovered to some degree but remain down by 6.2% as of 1:08 p.m. EDT.
Digital media and marketing software firm Adobe is forecast to report a dramatic slowdown in earnings-per-share growth when it posts fiscal first-quarter results late Thursday. On a year-over-year basis, earnings per share are seen rising 5% while sales climb 22%. Year-over-year earnings growth in the prior four quarters was 65%, 63%, 57% and 45%. While earnings growth has decelerated, sales growth has remained fairly stable the last four quarters at 24%, 24%, 24% and 23%.